methenamine has been researched along with Porphyria, Acute Intermittent in 1 studies
Methenamine: An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)
hexamethylenetetramine : A polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms.
Porphyria, Acute Intermittent: An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Webber, PR | 1 |
Aarsand, AK | 1 |
Sandvik, AK | 1 |
Skadberg, Ø | 1 |
Lindberg, M | 1 |
Sandberg, S | 1 |
1 other study available for methenamine and Porphyria, Acute Intermittent
Article | Year |
---|---|
Acute porphyrias may be overlooked in patients taking methenamine hippurate.
Topics: Aged; Aminolevulinic Acid; Artifacts; Diagnostic Errors; Female; Hippurates; Humans; Methenamine; Po | 2010 |